![Matthew During](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthew During
Keine laufenden Positionen mehr
Profil
Matthew During is the founder of Merlin Pharma Pvt Ltd. (1993), NightstaRx Ltd. (2014), Nightstar Therapeutics Ltd. (2014), and Ovid Therapeutics, Inc. (2014).
At Ovid Therapeutics, Inc., he held the titles of President, Director & Chief Scientific Officer from 2015 to 2019.
Dr. During's former jobs include Senior Manager at Bridgewater Associates LP (2014), Professor-Neurosurgery at Yale University (1989-2000), Professor at Cornell University, and Professor at The Ohio State University (2006-2014).
Dr. During received his undergraduate and doctorate degrees from Auckland University.
Dr. During is also the founder of Neurologix, Inc...
Ehemalige bekannte Positionen von Matthew During
| Unternehmen | Position | Ende |
|---|---|---|
| OVID THERAPEUTICS INC. | Vorstandsvorsitzender | 01.03.2015 |
Bridgewater Associates LP
 Bridgewater Associates LP Investment ManagersFinance Bridgewater structures portfolios in a manner designed to produce consistent and uncorrelated returns. The firm believes investors can improve their portfolios’ overall results by separately creating a well-diversified beta portfolio that is balanced against environmental biases and calibrated to one's targeted returns, and a well-diversified alpha portfolio that reduces systematic biases (and is calibrated to one's targeted returns). | Corporate Officer/Principal | 01.12.2014 |
The Ohio State University
 The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01.12.2014 |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01.01.2006 |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01.01.2000 |
Ausbildung von Matthew During
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
96
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
Ovid Therapeutics, Inc.
 Ovid Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides medicines to children and adults with neurological disorders | Health Technology |
Bridgewater Associates LP
Bridgewater Associates LP Investment ManagersFinance Bridgewater structures portfolios in a manner designed to produce consistent and uncorrelated returns. The firm believes investors can improve their portfolios’ overall results by separately creating a well-diversified beta portfolio that is balanced against environmental biases and calibrated to one's targeted returns, and a well-diversified alpha portfolio that reduces systematic biases (and is calibrated to one's targeted returns). | Finance |
Auckland University
 Auckland University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Ohio State University
The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Neurologix, Inc. /Old/
 Neurologix, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Develops therapies for the brain and central nervous system | Commercial Services |
Merlin Pharma Pvt Ltd.
 Merlin Pharma Pvt Ltd. Merlin Pharma Pvt Ltd. is a private company based in Mumbai, India. | |
NightstaRx Ltd.
 NightstaRx Ltd. Medical/Nursing ServicesHealth Services development of therapies for retinal dystrophies | Health Services |
Nightstar Therapeutics Ltd.
 Nightstar Therapeutics Ltd. BiotechnologyHealth Technology Operates as a gene therapy company that develops novel treatments for patients suffering from inherited retinal diseases | Health Technology |
